Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A9 | P48067 | 1/20 | 0.39 |
| ▸ | ALB | P02768 | 1/20 | 0.39 |
| ▸ | GSR | P00390 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.35 |
| ▸ | PLAU | P00749 | 2/20 | 0.33 |
| ▸ | PLAUR | Q03405 | 2/20 | 0.33 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.33 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.32 |
| ▸ | CACNA2D1 | P54289 | 1/20 | 0.31 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.31 |
| ▸ | CACNB1 | Q02641 | 1/20 | 0.31 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.31 |
| ▸ | DPP4 | P27487 | 1/20 | 0.31 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.31 |
| ▸ | TACR1 | P25103 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL410472 | 0.98 | SLC6A9 (0.40) | SLC6A9ALBGSRHSD17B10CPB2 | |
| SCHEMBL1673011 | 0.98 | SLC6A9 (0.40) | SLC6A9ALBGSRHSD17B10CPB2 | |
| SCHEMBL16800548 | 0.94 | GSR (0.44) | SLC6A9ALBGSRHSD17B10CPB2 | |
| SCHEMBL23504921 | 0.89 | SLC6A9 (0.42) | SLC6A9ALBGSRHSD17B10CACNA2D1 | |
| SCHEMBL24507466 | 0.84 | SLC6A9 (0.41) | SLC6A9ALBHSD17B10FOLH1CACNA2D1 | |
| SCHEMBL30973670 | 0.83 | ALB (0.39) | SLC6A9ALBGSRFOLH1 | |
| SCHEMBL19403269 | 0.83 | S1PR1 (0.42) | SLC6A9ALBHSD17B10 | |
| SCHEMBL19605846 | 0.83 | S1PR1 (0.42) | SLC6A9ALBHSD17B10 | |
| SCHEMBL14546791 | 0.82 | SLC6A9 (0.36) | SLC6A9ALBGSRHSD17B10PLAU | |
| SCHEMBL820875 | 0.81 | GSR (0.50) | GSRCPB2PLAUPLAURRNPEP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9402924-B2 | Diagnostic compounds for targeting a chemokine receptors | GUERBET (FR) | 2016-08-02 | — | — | US | disclosed |
| US-8367039-B2 | Compounds for the diagnosis of diseases associated with VCAM expression | GUERBET (FR) | 2013-02-05 | — | — | US | disclosed |
| US-20110200533-A1 | COMPOUNDS FOR THE DIAGNOSIS OF DISEASES ASSOCIATED WITH VCAM EXPRESSION | GUERBET (FR) | 2011-08-18 | — | — | US | disclosed |
| US-20100143250-A1 | COMPOUNDS FOR THE DIAGNOSIS OF APOPTOSIS | GUERBET (FR) | 2010-06-10 | — | — | US | disclosed |
| US-20090202435-A1 | Diagnostic compounds for targeting a chemokine receptors | GUERBET (FR) | 2009-08-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110200533-A1 | COMPOUNDS FOR THE DIAGNOSIS OF DISEASES ASSOCIATED WITH VCAM EXPRESSION | VCAM1, SLC7A11, QPCTL | SLC6A9 116/4885ALB 2581/4885GSR 3174/4885 |
| US-20100143250-A1 | COMPOUNDS FOR THE DIAGNOSIS OF APOPTOSIS | TPX2, VIP, BAX | SLC6A9 1516/4885ALB 3427/4885GSR 1874/4885 |
| US-20090202435-A1 | Diagnostic compounds for targeting a chemokine receptors | CCL2, ACKR3, CCR5 | SLC6A9 3834/4885ALB 4195/4885GSR 3383/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.